These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The molecular basis for the difference in immune hemolysis activity of the Chido and Rodgers isotypes of human complement component C4. Isenman DE; Young JR J Immunol; 1984 Jun; 132(6):3019-27. PubMed ID: 6609966 [TBL] [Abstract][Full Text] [Related]
4. Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65. Ollert MW; Kadlec JV; Petrella EC; Bredehorst R; Vogel CW Cancer Res; 1993 Feb; 53(3):592-9. PubMed ID: 8425193 [TBL] [Abstract][Full Text] [Related]
5. A single arginine to tryptophan interchange at beta-chain residue 458 of human complement component C4 accounts for the defect in classical pathway C5 convertase activity of allotype C4A6. Implications for the location of a C5 binding site in C4. Ebanks RO; Jaikaran AS; Carroll MC; Anderson MJ; Campbell RD; Isenman DE J Immunol; 1992 May; 148(9):2803-11. PubMed ID: 1573269 [TBL] [Abstract][Full Text] [Related]
6. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes. Brown EJ; Ramsey J; Hammer CH; Frank MM J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833 [TBL] [Abstract][Full Text] [Related]
7. Role of the fourth complement component (C4) in the regulation of contact sensitivity. III. In vivo effect of purified C4. Dieli F; Sireci G; Lio D; Salerno A Cell Immunol; 1989 Oct; 123(1):236-43. PubMed ID: 2776219 [TBL] [Abstract][Full Text] [Related]
8. Control of C1 activation by nascent C3b and C4b: a mechanism of feedback inhibition. Ziccardi RJ J Immunol; 1986 May; 136(9):3378-83. PubMed ID: 3485688 [TBL] [Abstract][Full Text] [Related]
9. Active sites in complement components C5 and C3 identified by proximity to indels in the C3/4/5 protein family. Low PJ; Ai R; Ogata RT J Immunol; 1999 Jun; 162(11):6580-8. PubMed ID: 10352274 [TBL] [Abstract][Full Text] [Related]
10. Amino acid residues 1101-1105 of the isotypic region of human C4B is important to the covalent binding activity of complement component C4. Reilly BD; Levine RP; Skanes VM J Immunol; 1991 Nov; 147(9):3018-23. PubMed ID: 1919003 [TBL] [Abstract][Full Text] [Related]
11. Post-transcriptional regulation of complement C4 in low C4-producing strain of mouse. Nakayama K; Pattanakitsakul S; Yokoyama S; Kimura H; Nonaka M; Takahashi M Immunogenetics; 1990; 31(5-6):361-7. PubMed ID: 2370081 [TBL] [Abstract][Full Text] [Related]
12. Restriction fragment length polymorphism of the murine C4 and Slp genes: two C4 groups. Miller RD; Aizawa Y; Shreffler DC J Immunol; 1992 Nov; 149(9):2926-34. PubMed ID: 1357031 [TBL] [Abstract][Full Text] [Related]
13. Induction of contact sensitivity by cell-associated immunocomplexes requires activation of the early complement components. Lio D; Sireci G; Gervasi F; Dieli F; Salerno A Int J Exp Pathol; 1992 Dec; 73(6):741-50. PubMed ID: 1493103 [TBL] [Abstract][Full Text] [Related]
14. Role of the fourth complement component (C4) in the regulation of contact sensitivity. II. Qualitative differences between C4 molecules from high- and low-C4 mouse strains. Dieli F; Sireci G; Di Pace MR; Salerno A Cell Immunol; 1989 Apr; 119(2):243-51. PubMed ID: 2702693 [TBL] [Abstract][Full Text] [Related]
15. Evidence for the involvement of arginine 462 and the flanking sequence of human C4 beta-chain in mediating C5 binding to the C4b subcomponent of the classical complement pathway C5 convertase. Ebanks RO; Isenman DE J Immunol; 1995 Mar; 154(6):2808-20. PubMed ID: 7876551 [TBL] [Abstract][Full Text] [Related]
16. Substrate specificities of the protease of mouse serum Ra-reactive factor. Ogata RT; Low PJ; Kawakami M J Immunol; 1995 Mar; 154(5):2351-7. PubMed ID: 7868903 [TBL] [Abstract][Full Text] [Related]
17. C4 does not bind to human and rabbit IgM during activation of the classical complement pathway on the red cell. Circolo A; Borsos T J Immunol; 1982 Oct; 129(4):1485-8. PubMed ID: 7108214 [TBL] [Abstract][Full Text] [Related]
18. Role of antibody and complement in the immune clearance and destruction of erythrocytes. II. Molecular nature of IgG and IgM complement-fixing sites and effects of their interaction with serum. Schreiber AD; Frank MM J Clin Invest; 1972 Mar; 51(3):583-9. PubMed ID: 4622104 [TBL] [Abstract][Full Text] [Related]
19. Studies of monkey complement: measurement of cynomolgus monkey CH50, ACH50, C4, C2 and C3. Xu H; Kitano E; Sato Y; Kobayashi C; Firdawes S; Kitamura H; Fukuzawa M; Miyagawa S Xenotransplantation; 2008 Feb; 15(1):14-9. PubMed ID: 18333909 [TBL] [Abstract][Full Text] [Related]
20. The coding sequence of the hemolytically inactive C4A6 allotype of human complement component C4 reveals that a single arginine to tryptophan substitution at beta-chain residue 458 is the likely cause of the defect. Anderson MJ; Milner CM; Cotton RG; Campbell RD J Immunol; 1992 May; 148(9):2795-802. PubMed ID: 1573268 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]